Fludarabine
HPV-Related Squamous Cell Carcinoma
Christian HinrichsSmall moleculePhase 2Active
B
59/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 44/ 100
- Competitive Position
- 95/ 100
Competitive context
16 Active assets in the HPV-Related Squamous Cell Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Christian Hinrichs | Phase 2 | B |
e7 tcr-t cells Christian Hinrichs | Phase 2 | B |
9-valent human papillomavirus recombinant vaccine Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 | B |
Retifanlimab Jennifer Dorth | Phase 2 | CCC |
scg142 SCG Cell Therapy Pte. Ltd. | Phase 1/2 | CCC |
View all 18 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →